Search Within

Vicky Makker

Formats
  1. Meeting Abstract (143)
  2. Journal Article (111)
  3. Review (9)
  4. Editorial (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (269)
  2. GDMT, Medicine (269)
  3. Gynecologic Medicine Service (269)
  4. Gynecology Disease Management Team (269)
  5. Solid Tumor Oncology Division (269)
  6. Surgery (94)

More Groups

People
  1. Carol Aghajanian (91)
  2. Nadeem Abu-Rustum (77)
  3. Mario Leitao (49)
  4. Alexia Iasonos (47)
  5. Kaled Alektiar (45)
  6. Qin Zhou (43)

More People

Years
  1. 2025 (13)
  2. 2024 (35)
  3. 2023 (39)
  4. 2022 (36)
  5. 2021 (19)
  6. 2020 (26)

More Years

Publications
  1. Gynecologic Oncology (65)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Gynecological Cancer (38)
  4. Annals of Oncology (23)
  5. Gynecologic Oncology Reports (8)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier B.V. (73)
  2. American Society of Clinical Oncology (61)
  3. Lippincott Williams & Wilkins (39)
  4. Oxford University Press (26)
  5. American Association for Cancer Research (12)
  6. Elsevier Inc. (9)

More Publishers

Results (269)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized, double-blind, phase II study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib versus pembrolizumab plus lenvatinib among patients with previously-treated mismatch repair proficient advanced endometrial cancer
    Meeting Abstract

    Girda, E.; Makker, V.; Marth, C.; Van Gorp, T.; Mirza, M.; Shapira-Frommer, R.; Suttner, L.; Groisberg, R.; Jin, F.; O'Malley, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Prognostic value of aggressive histology in surgically-staged, clinically uterine-confined endometrial carcinoma
    Meeting Abstract

    Dagher, C.; Mueller, J.; Abu-Rustum, N.; Sonoda, Y.; Momeni-Boroujeni, A.; Makker, V.; O'Cearbhaill, R.; Alektiar, K.; Leitao, M.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and tumor mutational burden are associated with higher microbiome diversity in the reproductive tract
    Meeting Abstract

    Rubinstein, M.; Gradissimo, A.; Taur, Y.; Varice, N.; Roche, K. L.; Broach, V.; Leitao, M.; Sonoda, Y.; Weigelt, B.; Zivanovic, O.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: Primary results of the phase III ENGOT-En9/LEAP-001 study
    Meeting Abstract

    Marth, C.; Moore, R.; Bidzinski, M.; Pignata, S.; Ayhan, A.; Rubio, M. J.; Beiner, M.; Hall, M.; Vulsteke, C.; Braicu, E. I.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of trastuzumab deruxtecan among patients with HER2-expressing solid tumors: Biomarker and subgroup analyses from the cervical, endometrial, and ovarian cancer cohorts of the DESTINY-PanTumor02 study
    Meeting Abstract

    Makker, V.; Oaknin, A.; Manso, L.; González-Martín, A.; Lugowska, I.; Meric-Bernstam, F.; Lorusso, D.; Banerjee, S.; Liao, J.; Siena, S.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53wt advanced or recurrent endometrial cancer: Follow-up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Haluska, P.; Pérez-Fidalgo, J. A.; Vergote, I.; Hamilton, E.; de Giorgi, U.; Van Gorp, T.; Lübbe, K.; Zikan, M.; Helpman, L.; Miller, D. S.; more...
    Asia-Pacific Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • ENGOT-EN20/GOG-3083/XPORT-EC-042 A PHASE 3, randomized, placebo-controlled, double-blind, multicenter trial of Selinexor in maintenance therapy for patients with p53 wild-type, advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Webber, K.; Vergote, I.; Mirza, M. R.; Coleman, R.; Fidalgo, J. A. P.; Monk, B. J.; Valabrega, G.; Slomovitz, B.; Van Gorp, T.; Moore, K.; more...
    Asia-Pacific Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Advancing global health equity in oncology clinical trial access
    Editorial

    Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: A multicenter retrospective cohort study
    Journal Article

    Dagher, C.; Bjerre Trent, P.; Alwaqfi, R.; Davidson, B.; Ellenson, L.; Zhou, Q. C.; Iasonos, A.; Mueller, J. J.; Alektiar, K.; Makker, V.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
    Journal Article

    Rios-Doria, E.; Abu-Rustum, N. R.; Alektiar, K. M.; Makker, V.; Liu, Y. L.; Zamarin, D.; Friedman, C. F.; Aghajanian, C.; Ellenson, L. H.; Chiang, S.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save